Drug risk assessment: A case for large trials with lean protocols
- 1 November 1994
- journal article
- Published by Wiley in Pharmacoepidemiology and Drug Safety
- Vol. 3 (6) , 321-327
- https://doi.org/10.1002/pds.2630030605
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- First dose hypotension with enalapril and prazosin in congestive heart failureInternational Journal of Cardiology, 1991
- The clinical trial as a paradigm for epidemiologic researchJournal of Clinical Epidemiology, 1989
- Epidemiologic analyses of causation: the unlearned scientific lessons of randomized trialsJournal of Clinical Epidemiology, 1989
- Preliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1988
- The experimental paradigm and observational studies of cause-effect relationships in clinical medicineJournal of Chronic Diseases, 1987
- Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathyThe American Journal of Cardiology, 1986
- PRESCRIPTION EVENT MONITORINGThe Lancet, 1986
- Post-marketing studies of drug efficacy: How?The American Journal of Medicine, 1984
- Identification of adverse reactions to new drugs. II--How were 18 important adverse reactions discovered and with what delays?BMJ, 1983
- Inadequacy of the literature on the relationship between drugs, ulcers, and gastrointestinal bleedingGastroenterology, 1982